Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0052 | 0.0031 | 0.0031 |
Echinococcus granulosus | sodium dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0032 |
Trichomonas vaginalis | reverse transcriptase [C. elegans], putative | 0.0046 | 0 | 0.5 |
Trichomonas vaginalis | NeSL-1_NeSL reverse transcriptases, putative | 0.0046 | 0 | 0.5 |
Onchocerca volvulus | 0.0307 | 0.1317 | 1 | |
Mycobacterium tuberculosis | Possible maturase | 0.0046 | 0 | 0.5 |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0307 | 0.1317 | 0.1317 |
Schistosoma mansoni | sodium-dependent amino acid transporter | 0.0052 | 0.0031 | 0.0031 |
Entamoeba histolytica | kinesin, putative | 0.0253 | 0.1044 | 0.5 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0235 | 0.0955 | 0.7185 |
Plasmodium falciparum | kinesin-5 | 0.0253 | 0.1044 | 1 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0031 |
Echinococcus granulosus | uncharacterized sodium dependent transporter | 0.0052 | 0.0031 | 0.0032 |
Trypanosoma brucei | RNA helicase, putative | 0.2026 | 1 | 1 |
Echinococcus multilocularis | sodium:chloride dependent neurotransmitter | 0.0052 | 0.0031 | 0.0032 |
Echinococcus granulosus | uncharacterized sodium dependent transporter | 0.0052 | 0.0031 | 0.0032 |
Giardia lamblia | Kinesin-5 | 0.0253 | 0.1044 | 1 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0031 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0307 | 0.1317 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0031 | 0.0236 |
Brugia malayi | Kinesin motor domain containing protein | 0.0253 | 0.1044 | 0.793 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0046 | 0 | 0.5 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0052 | 0.0031 | 0.0032 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0052 | 0.0031 | 0.0031 |
Onchocerca volvulus | 0.0052 | 0.0031 | 0.0236 | |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0052 | 0.0031 | 0.0031 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0052 | 0.0031 | 0.0032 |
Loa Loa (eye worm) | norepinephrine transporter | 0.0307 | 0.1317 | 1 |
Brugia malayi | follicle stimulating hormone receptor | 0.0235 | 0.0955 | 0.7252 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 0.1317 | 1 |
Echinococcus multilocularis | uncharacterized sodium dependent transporter | 0.0052 | 0.0031 | 0.0032 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0057 | 0.0054 | 0.0181 |
Treponema pallidum | sodium- and chloride- dependent transporter | 0.0307 | 0.1317 | 0.5 |
Echinococcus granulosus | serotonin transporter | 0.0307 | 0.1317 | 0.1373 |
Loa Loa (eye worm) | serotonin transporter b | 0.0307 | 0.1317 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0031 | 0.0236 |
Schistosoma mansoni | hypothetical protein | 0.1692 | 0.8315 | 0.8315 |
Trichomonas vaginalis | reverse transcriptases, putative | 0.0046 | 0 | 0.5 |
Echinococcus multilocularis | kinesin family 1 | 0.1945 | 0.9591 | 1 |
Echinococcus granulosus | sodium and chloride dependent glycine | 0.0052 | 0.0031 | 0.0032 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 0.1317 | 1 |
Schistosoma mansoni | sodium/chloride dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0031 |
Toxoplasma gondii | kinesin motor domain-containing protein | 0.0253 | 0.1044 | 1 |
Chlamydia trachomatis | Ssodium-dependent amino acid transporter | 0.0052 | 0.0031 | 0.5 |
Echinococcus granulosus | kinesin family 1 | 0.1945 | 0.9591 | 1 |
Onchocerca volvulus | 0.0052 | 0.0031 | 0.0236 | |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0031 |
Echinococcus multilocularis | sodium and chloride dependent glycine | 0.0052 | 0.0031 | 0.0032 |
Trichomonas vaginalis | reverse transcriptases, putative | 0.0046 | 0 | 0.5 |
Onchocerca volvulus | 0.0052 | 0.0031 | 0.0236 | |
Schistosoma mansoni | norepinephrine/norepinephrine transporter | 0.0052 | 0.0031 | 0.0031 |
Loa Loa (eye worm) | hypothetical protein | 0.0307 | 0.1317 | 1 |
Loa Loa (eye worm) | kinesin-like protein KLP2 | 0.0253 | 0.1044 | 0.788 |
Brugia malayi | Cytochrome P450 family protein | 0.0057 | 0.0054 | 0.0413 |
Echinococcus multilocularis | serotonin transporter | 0.0307 | 0.1317 | 0.1373 |
Brugia malayi | hypothetical protein | 0.0052 | 0.0031 | 0.0236 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0031 |
Schistosoma mansoni | kinesin eg-5 | 0.0253 | 0.1044 | 0.1044 |
Brugia malayi | Sodium:neurotransmitter symporter family protein | 0.0052 | 0.0031 | 0.0236 |
Echinococcus granulosus | sodium:chloride dependent neurotransmitter | 0.0052 | 0.0031 | 0.0032 |
Echinococcus multilocularis | sodium dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0032 |
Schistosoma mansoni | sodium-dependent neurotransmitter transporter | 0.0052 | 0.0031 | 0.0031 |
Schistosoma mansoni | sodium/chloride dependent transporter | 0.0307 | 0.1317 | 0.1317 |
Plasmodium vivax | kinesin-5 | 0.0253 | 0.1044 | 1 |
Loa Loa (eye worm) | solute carrier family 6 member 4 | 0.0307 | 0.1317 | 1 |
Brugia malayi | Sodium:neurotransmitter symporter family protein 1, putative | 0.0052 | 0.0031 | 0.0236 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 100 uM | Antibacterial activity against UDP-MurNAc-pentapeptide synthetase from Streptococcus pneumoniae. | ChEMBL. | 14684340 |
IC50 (binding) | > 100 uM | Antibacterial activity against UDP-MurNAc-pentapeptide synthetase from Streptococcus pneumoniae. | ChEMBL. | 14684340 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.